Literature DB >> 23135279

Toll-like receptor 11 (TLR11) prevents Salmonella penetration into the murine Peyer patches.

Zhongcheng Shi1, Zhenyu Cai, Jingcui Yu, Tingting Zhang, Shu Zhao, Emanuel Smeds, Qingyuan Zhang, Fen Wang, Changhong Zhao, Songbin Fu, Sankar Ghosh, Dekai Zhang.   

Abstract

Toll-like receptors (TLRs) are key molecular sensors used by the mammalian innate immune system to detect microorganisms. Although TLR functions in colonic immune homeostasis and tolerance to commensal bacteria have been intensively researched, the precise roles of different TLRs in response to pathogen infection in the gut remain elusive. Peyer patches are the major entrance of Salmonella infection and antigen transportation in intestine. Here, we report that, in contrast to TLR5 as a "carrier of Salmonella," TLR11 works as a "blocker of Salmonella" to prevent highly invasive Salmonella from penetrating into the murine Peyer patches and spreading systemically. TLR11 plays an important role in mediating TNF-α induction and systemic inflammation in response to Salmonella infection. Remarkably, in mice lacking TLR11, apparent hemorrhages at Peyer patches are induced by highly invasive Salmonella, a phenotype resembling human Salmonella infection. Therefore, our results indicate a potentially important role for TLR11 in preventing murine intestinal infection and modulating antigen transportation in the gut and imply an important role for various TLRs in cooperation with tight control of pathogens penetrating into Peyer patches. The TLR11 knock-out mouse can serve as a good animal model to study Salmonella infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23135279      PMCID: PMC3527929          DOI: 10.1074/jbc.M112.411009

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

Review 2.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 3.  Salmonella: a model for bacterial pathogenesis.

Authors:  M E Ohl; S I Miller
Journal:  Annu Rev Med       Date:  2001       Impact factor: 13.739

4.  Toll-like receptors are temporally involved in host defense.

Authors:  David S Weiss; Bärbel Raupach; Kiyoshi Takeda; Shizuo Akira; Arturo Zychlinsky
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

5.  A toll-like receptor that prevents infection by uropathogenic bacteria.

Authors:  Dekai Zhang; Guolong Zhang; Matthew S Hayden; Matthew B Greenblatt; Crystal Bussey; Richard A Flavell; Sankar Ghosh
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

6.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5.

Authors:  F Hayashi; K D Smith; A Ozinsky; T R Hawn; E C Yi; D R Goodlett; J K Eng; S Akira; D M Underhill; A Aderem
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

Review 7.  Salmonella interactions with host cells: type III secretion at work.

Authors:  J E Galán
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

8.  Vi-Suppressed wild strain Salmonella typhi cultured in high osmolarity is hyperinvasive toward epithelial cells and destructive of Peyer's patches.

Authors:  L Zhao; T Ezak; Z Y Li; Y Kawamura; K Hirose; H Watanabe
Journal:  Microbiol Immunol       Date:  2001       Impact factor: 1.955

9.  Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection.

Authors:  Koichi Tabeta; Philippe Georgel; Edith Janssen; Xin Du; Kasper Hoebe; Karine Crozat; Suzanne Mudd; Louis Shamel; Sosathya Sovath; Jason Goode; Lena Alexopoulou; Richard A Flavell; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

Review 10.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

View more
  11 in total

Review 1.  Trial Watch: Toll-like receptor agonists in cancer immunotherapy.

Authors:  Melody Smith; Elena García-Martínez; Michael R Pitter; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-10-11       Impact factor: 8.110

2.  Identification and expression analysis of a TLR11 family gene in the sea urchin Strongylocentrotus intermedius.

Authors:  Yinan Wang; Shixiong Cheng; Yaqing Chang; Kaiquan Li; Yang Chen; Yi Wang
Journal:  Immunogenetics       Date:  2017-10-26       Impact factor: 2.846

Review 3.  Same species, different diseases: how and why typhoidal and non-typhoidal Salmonella enterica serovars differ.

Authors:  Ohad Gal-Mor; Erin C Boyle; Guntram A Grassl
Journal:  Front Microbiol       Date:  2014-08-04       Impact factor: 5.640

Review 4.  Innate Sensing of the Gut Microbiota: Modulation of Inflammatory and Autoimmune Diseases.

Authors:  Aline Ignacio; Camila Ideli Morales; Niels Olsen Saraiva Câmara; Rafael Ribeiro Almeida
Journal:  Front Immunol       Date:  2016-02-19       Impact factor: 7.561

5.  Toll-Like Receptor 11 (TLR11) Interacts with Flagellin and Profilin through Disparate Mechanisms.

Authors:  Hirotsugu Hatai; Alice Lepelley; Wangyong Zeng; Matthew S Hayden; Sankar Ghosh
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

6.  Rapid Bladder Interleukin-10 Synthesis in Response to Uropathogenic Escherichia coli Is Part of a Defense Strategy Triggered by the Major Bacterial Flagellar Filament FliC and Contingent on TLR5.

Authors:  Dhruba Acharya; Matthew J Sullivan; Benjamin L Duell; Kelvin G K Goh; Lahiru Katupitiya; Dean Gosling; Michelle N Chamoun; Asha Kakkanat; Debasish Chattopadhyay; Michael Crowley; David K Crossman; Mark A Schembri; Glen C Ulett
Journal:  mSphere       Date:  2019-11-27       Impact factor: 4.389

Review 7.  How to translate basic knowledge into clinical application of biologic therapy in spondyloarthritis.

Authors:  Chung-Tei Chou
Journal:  Clin Dev Immunol       Date:  2013-06-11

Review 8.  Trial Watch: Toll-like receptor agonists for cancer therapy.

Authors:  Erika Vacchelli; Alexander Eggermont; Catherine Sautès-Fridman; Jérôme Galon; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-06-10       Impact factor: 8.110

9.  Trial Watch: Toll-like receptor agonists in oncological indications.

Authors:  Fernando Aranda; Erika Vacchelli; Florine Obrist; Alexander Eggermont; Jérôme Galon; Catherine Sautès-Fridman; Isabelle Cremer; Jan Henrik Ter Meulen; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-08-01       Impact factor: 8.110

Review 10.  Bacterial flagellin-a potent immunomodulatory agent.

Authors:  Irshad A Hajam; Pervaiz A Dar; Imam Shahnawaz; Juan Carlos Jaume; John Hwa Lee
Journal:  Exp Mol Med       Date:  2017-09-01       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.